Why is Bafna Pharma. falling/rising?

As of 26-Aug, Bafna Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 99.00, which reflects a rise of Rs 4.1 or 4.32%. The stock has shown a trend reversal, gaining after five consecutive days of decline, and opened with a gap up of 3.92% today. It has outperformed its sector by 6.12% and reached an intraday high of Rs 99. The stock has generated a return of 15.21% over the past year, while its profits have surged by 944%, indicating strong financial performance. Additionally, the company has a low Debt to EBITDA ratio of 1.30 times, which supports its ability to service debt effectively. Institutional investors have also increased their stake by 0.81%, suggesting growing confidence in the company's fundamentals.
In the broader market context, while the stock has performed well, the benchmark index, Sensex, has only seen a slight decline of 1.05% over the past week and a negative return of 1.12% over the past year. This indicates that Bafna Pharmaceuticals has significantly outperformed the market, particularly with a 29.41% year-to-date return compared to the Sensex's 3.39%. Despite a recent drop in investor participation, the stock's liquidity remains adequate for trading, and its current performance stands in stark contrast to the broader market's negative trends.